Further analysis of the activation status of either CHK1, CHK2 or ERα in ERα-positive BC cells revealed that no correlation between CHK2 and ERα activation exists in ERα-positive cells even if the cell lines are stratified as belonging to the LumA or LumB tumor phenotype (Fig. 2C). The gene discussed is CHEK2; the disease is breast cancer.